nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—FGA—schizophrenia	0.78	1	CbGaD
Sucralfate—EGF—telencephalic ventricle—schizophrenia	0.00971	0.125	CbGeAlD
Sucralfate—FGB—blood plasma—schizophrenia	0.00741	0.095	CbGeAlD
Sucralfate—FGA—blood plasma—schizophrenia	0.00634	0.0813	CbGeAlD
Sucralfate—EGF—blood plasma—schizophrenia	0.00463	0.0594	CbGeAlD
Sucralfate—PGA5—nervous system—schizophrenia	0.00324	0.0416	CbGeAlD
Sucralfate—PGA5—central nervous system—schizophrenia	0.00312	0.04	CbGeAlD
Sucralfate—FGB—gonad—schizophrenia	0.00311	0.0399	CbGeAlD
Sucralfate—FGB—blood—schizophrenia	0.00271	0.0348	CbGeAlD
Sucralfate—FGA—gonad—schizophrenia	0.00266	0.0342	CbGeAlD
Sucralfate—EGF—forebrain—schizophrenia	0.00254	0.0325	CbGeAlD
Sucralfate—PGA5—brain—schizophrenia	0.00248	0.0318	CbGeAlD
Sucralfate—FGB—endocrine gland—schizophrenia	0.00235	0.0302	CbGeAlD
Sucralfate—EGF—telencephalon—schizophrenia	0.00233	0.0299	CbGeAlD
Sucralfate—FGA—blood—schizophrenia	0.00232	0.0298	CbGeAlD
Sucralfate—FGA—endocrine gland—schizophrenia	0.00201	0.0258	CbGeAlD
Sucralfate—EGF—gonad—schizophrenia	0.00195	0.025	CbGeAlD
Sucralfate—FGA—nervous system—schizophrenia	0.00188	0.0242	CbGeAlD
Sucralfate—FGA—central nervous system—schizophrenia	0.00181	0.0233	CbGeAlD
Sucralfate—FGA—cerebellum—schizophrenia	0.00177	0.0228	CbGeAlD
Sucralfate—EGF—blood—schizophrenia	0.0017	0.0218	CbGeAlD
Sucralfate—FGF2—midbrain—schizophrenia	0.00148	0.019	CbGeAlD
Sucralfate—EGF—endocrine gland—schizophrenia	0.00147	0.0189	CbGeAlD
Sucralfate—FGA—brain—schizophrenia	0.00144	0.0185	CbGeAlD
Sucralfate—EGF—nervous system—schizophrenia	0.00138	0.0177	CbGeAlD
Sucralfate—EGF—central nervous system—schizophrenia	0.00133	0.017	CbGeAlD
Sucralfate—EGF—cerebellum—schizophrenia	0.0013	0.0166	CbGeAlD
Sucralfate—FGF2—cerebellum—schizophrenia	0.00114	0.0147	CbGeAlD
Sucralfate—EGF—brain—schizophrenia	0.00105	0.0135	CbGeAlD
Sucralfate—FGF2—brain—schizophrenia	0.000928	0.0119	CbGeAlD
Sucralfate—ALB—brain—schizophrenia	0.000364	0.00467	CbGeAlD
Sucralfate—FGF2—Disease—FGA—schizophrenia	2.41e-05	0.000169	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—SLC6A3—schizophrenia	2.41e-05	0.000169	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—ERBB3—schizophrenia	2.4e-05	0.000168	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—ERBB3—schizophrenia	2.38e-05	0.000167	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—ERBB3—schizophrenia	2.38e-05	0.000167	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NPS—schizophrenia	2.38e-05	0.000167	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—AKT1—schizophrenia	2.38e-05	0.000167	CbGpPWpGaD
Sucralfate—EGF—Immune System—YWHAZ—schizophrenia	2.35e-05	0.000165	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—HTR2A—schizophrenia	2.34e-05	0.000164	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—IL1B—schizophrenia	2.34e-05	0.000164	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IL3RA—schizophrenia	2.33e-05	0.000164	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—DRD1—schizophrenia	2.33e-05	0.000164	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HTR2C—schizophrenia	2.33e-05	0.000164	CbGpPWpGaD
Sucralfate—EGF—Immune System—ERBB3—schizophrenia	2.3e-05	0.000161	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—HTR2A—schizophrenia	2.29e-05	0.000161	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—HTR2A—schizophrenia	2.29e-05	0.000161	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—AKT1—schizophrenia	2.27e-05	0.00016	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NTRK2—schizophrenia	2.27e-05	0.000159	CbGpPWpGaD
Sucralfate—EGF—Disease—NRG1—schizophrenia	2.27e-05	0.000159	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—DRD3—schizophrenia	2.26e-05	0.000159	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	2.24e-05	0.000157	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—AKT1—schizophrenia	2.24e-05	0.000157	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—EP300—schizophrenia	2.24e-05	0.000157	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CHRM1—schizophrenia	2.23e-05	0.000156	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—AKT1—schizophrenia	2.21e-05	0.000155	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	2.21e-05	0.000155	CbGpPWpGaD
Sucralfate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—schizophrenia	2.2e-05	0.000154	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—DRD4—schizophrenia	2.19e-05	0.000154	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—GSK3B—schizophrenia	2.19e-05	0.000154	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—APOE—schizophrenia	2.17e-05	0.000153	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL3RA—schizophrenia	2.17e-05	0.000152	CbGpPWpGaD
Sucralfate—EGF—Disease—YWHAZ—schizophrenia	2.17e-05	0.000152	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—AKT1—schizophrenia	2.16e-05	0.000152	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—AKT1—schizophrenia	2.16e-05	0.000152	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—GABRB2—schizophrenia	2.16e-05	0.000152	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—APOA1—schizophrenia	2.15e-05	0.000151	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—AKT1—schizophrenia	2.14e-05	0.00015	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TNF—schizophrenia	2.14e-05	0.00015	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—PLA2G4A—schizophrenia	2.13e-05	0.00015	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—AKT1—schizophrenia	2.13e-05	0.00015	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—APOE—schizophrenia	2.13e-05	0.00015	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—APOE—schizophrenia	2.13e-05	0.00015	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—AKT1—schizophrenia	2.13e-05	0.000149	CbGpPWpGaD
Sucralfate—EGF—Disease—ERBB3—schizophrenia	2.12e-05	0.000149	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NRG3—schizophrenia	2.12e-05	0.000149	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TLE1—schizophrenia	2.12e-05	0.000149	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—AKT1—schizophrenia	2.12e-05	0.000149	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HLA-E—schizophrenia	2.11e-05	0.000148	CbGpPWpGaD
Sucralfate—FGF2—Disease—SNAP25—schizophrenia	2.11e-05	0.000148	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—APOA1—schizophrenia	2.11e-05	0.000148	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—APOA1—schizophrenia	2.11e-05	0.000148	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—AKT1—schizophrenia	2.11e-05	0.000148	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GFAP—schizophrenia	2.09e-05	0.000147	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CNR1—schizophrenia	2.09e-05	0.000147	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—ESR1—schizophrenia	2.08e-05	0.000146	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—AKT1—schizophrenia	2.08e-05	0.000146	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GRM5—schizophrenia	2.07e-05	0.000145	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HTR7—schizophrenia	2.04e-05	0.000143	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—DRD2—schizophrenia	2.04e-05	0.000143	CbGpPWpGaD
Sucralfate—EGF—Disease—MTHFR—schizophrenia	2.04e-05	0.000143	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—ESR1—schizophrenia	2.03e-05	0.000143	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—ESR1—schizophrenia	2.03e-05	0.000143	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—EP300—schizophrenia	2.01e-05	0.000141	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—YWHAZ—schizophrenia	2.01e-05	0.000141	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TLE3—schizophrenia	2.01e-05	0.000141	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MPC2—schizophrenia	1.99e-05	0.00014	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—AKT1—schizophrenia	1.98e-05	0.000139	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—AKT1—schizophrenia	1.98e-05	0.000139	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—AKT1—schizophrenia	1.98e-05	0.000139	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—AKT1—schizophrenia	1.96e-05	0.000138	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—AKT1—schizophrenia	1.95e-05	0.000137	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—AKT1—schizophrenia	1.94e-05	0.000136	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—GSK3B—schizophrenia	1.94e-05	0.000136	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PRL—schizophrenia	1.93e-05	0.000135	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—FOS—schizophrenia	1.92e-05	0.000135	CbGpPWpGaD
Sucralfate—EGF—Disease—APOE—schizophrenia	1.9e-05	0.000133	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCK—schizophrenia	1.89e-05	0.000133	CbGpPWpGaD
Sucralfate—FGF2—Disease—HSPA1A—schizophrenia	1.89e-05	0.000133	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PRL—schizophrenia	1.89e-05	0.000133	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—GSK3B—schizophrenia	1.88e-05	0.000132	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—schizophrenia	1.88e-05	0.000132	CbGpPWpGaD
Sucralfate—FGF2—Disease—NOS1—schizophrenia	1.88e-05	0.000132	CbGpPWpGaD
Sucralfate—EGF—Disease—APOA1—schizophrenia	1.88e-05	0.000132	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC18A2—schizophrenia	1.87e-05	0.000131	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	1.86e-05	0.000131	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—GSK3B—schizophrenia	1.86e-05	0.000131	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	1.85e-05	0.00013	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PLCH2—schizophrenia	1.85e-05	0.00013	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PDE4B—schizophrenia	1.85e-05	0.00013	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—GSK3B—schizophrenia	1.85e-05	0.00013	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—GSK3B—schizophrenia	1.85e-05	0.00013	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—AKT1—schizophrenia	1.83e-05	0.000129	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCKAR—schizophrenia	1.82e-05	0.000128	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—FGA—schizophrenia	1.82e-05	0.000128	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—S100B—schizophrenia	1.8e-05	0.000126	CbGpPWpGaD
Sucralfate—EGF—Immune System—GSK3B—schizophrenia	1.78e-05	0.000125	CbGpPWpGaD
Sucralfate—EGF—Immune System—FOS—schizophrenia	1.77e-05	0.000124	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—ATP2A2—schizophrenia	1.77e-05	0.000124	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ADORA2A—schizophrenia	1.76e-05	0.000124	CbGpPWpGaD
Sucralfate—FGF2—Immune System—S100B—schizophrenia	1.76e-05	0.000124	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—AKT1—schizophrenia	1.75e-05	0.000123	CbGpPWpGaD
Sucralfate—FGF2—Disease—PRL—schizophrenia	1.74e-05	0.000122	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NDST3—schizophrenia	1.74e-05	0.000122	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—APOA1—schizophrenia	1.74e-05	0.000122	CbGpPWpGaD
Sucralfate—FGA—Disease—EP300—schizophrenia	1.73e-05	0.000122	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ERBB4—schizophrenia	1.72e-05	0.000121	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC6A1—schizophrenia	1.72e-05	0.000121	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—TNF—schizophrenia	1.7e-05	0.000119	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FGA—schizophrenia	1.69e-05	0.000119	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ERBB4—schizophrenia	1.68e-05	0.000118	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ACSL6—schizophrenia	1.65e-05	0.000116	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SLC27A5—schizophrenia	1.65e-05	0.000116	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NPY—schizophrenia	1.65e-05	0.000116	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NOTCH4—schizophrenia	1.65e-05	0.000116	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ATP2A2—schizophrenia	1.65e-05	0.000116	CbGpPWpGaD
Sucralfate—EGF—Disease—GSK3B—schizophrenia	1.64e-05	0.000115	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PLA2G4A—schizophrenia	1.62e-05	0.000113	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	1.61e-05	0.000113	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—schizophrenia	1.6e-05	0.000112	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—OXT—schizophrenia	1.59e-05	0.000111	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HTR1B—schizophrenia	1.59e-05	0.000111	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NRG1—schizophrenia	1.59e-05	0.000111	CbGpPWpGaD
Sucralfate—ALB—Metabolism—DAO—schizophrenia	1.57e-05	0.00011	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MEF2C—schizophrenia	1.57e-05	0.00011	CbGpPWpGaD
Sucralfate—FGF2—Disease—ERBB4—schizophrenia	1.55e-05	0.000109	CbGpPWpGaD
Sucralfate—FGF2—Immune System—NRG1—schizophrenia	1.55e-05	0.000109	CbGpPWpGaD
Sucralfate—FGF2—Immune System—MEF2C—schizophrenia	1.54e-05	0.000108	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—ATP2A2—schizophrenia	1.53e-05	0.000108	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HTR1A—schizophrenia	1.53e-05	0.000107	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—YWHAZ—schizophrenia	1.52e-05	0.000107	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PNP—schizophrenia	1.51e-05	0.000106	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NPS—schizophrenia	1.5e-05	0.000106	CbGpPWpGaD
Sucralfate—FGF2—Immune System—YWHAZ—schizophrenia	1.49e-05	0.000104	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ERBB3—schizophrenia	1.49e-05	0.000104	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HTR2C—schizophrenia	1.48e-05	0.000104	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—DRD1—schizophrenia	1.48e-05	0.000104	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ERBB3—schizophrenia	1.45e-05	0.000102	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—EP300—schizophrenia	1.44e-05	0.000101	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NTRK2—schizophrenia	1.44e-05	0.000101	CbGpPWpGaD
Sucralfate—FGF2—Disease—NRG1—schizophrenia	1.43e-05	0.000101	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HTR2A—schizophrenia	1.43e-05	0.0001	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—DRD3—schizophrenia	1.43e-05	0.0001	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NOS1—schizophrenia	1.41e-05	9.93e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NDUFV2—schizophrenia	1.4e-05	9.84e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—DRD4—schizophrenia	1.39e-05	9.74e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—YWHAZ—schizophrenia	1.37e-05	9.64e-05	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—AKT1—schizophrenia	1.35e-05	9.48e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—AKT1—schizophrenia	1.35e-05	9.47e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—ERBB3—schizophrenia	1.34e-05	9.43e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—APOE—schizophrenia	1.33e-05	9.34e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CNR1—schizophrenia	1.32e-05	9.3e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PIP4K2A—schizophrenia	1.32e-05	9.25e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—APOA1—schizophrenia	1.31e-05	9.23e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL1B—schizophrenia	1.31e-05	9.21e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	1.31e-05	9.18e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—DRD2—schizophrenia	1.29e-05	9.08e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HTR7—schizophrenia	1.29e-05	9.08e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—MTHFR—schizophrenia	1.29e-05	9.06e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—EP300—schizophrenia	1.27e-05	8.94e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ESR1—schizophrenia	1.27e-05	8.91e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EP300—schizophrenia	1.24e-05	8.7e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC6A3—schizophrenia	1.22e-05	8.6e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PRL—schizophrenia	1.22e-05	8.57e-05	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—AKT1—schizophrenia	1.22e-05	8.54e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EP300—schizophrenia	1.21e-05	8.53e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EP300—schizophrenia	1.21e-05	8.53e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—APOE—schizophrenia	1.2e-05	8.44e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP26B1—schizophrenia	1.19e-05	8.37e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—APOA1—schizophrenia	1.19e-05	8.34e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—EP300—schizophrenia	1.17e-05	8.23e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TNF—schizophrenia	1.17e-05	8.22e-05	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—AKT1—schizophrenia	1.17e-05	8.2e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—GSK3B—schizophrenia	1.15e-05	8.09e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—S100B—schizophrenia	1.14e-05	7.99e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—GSK3B—schizophrenia	1.13e-05	7.92e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FOS—schizophrenia	1.12e-05	7.86e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PLA2G4A—schizophrenia	1.1e-05	7.72e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ERBB4—schizophrenia	1.09e-05	7.64e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—EP300—schizophrenia	1.08e-05	7.6e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TPH1—schizophrenia	1.06e-05	7.46e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GCLM—schizophrenia	1.06e-05	7.46e-05	CbGpPWpGaD
Sucralfate—FGA—Disease—AKT1—schizophrenia	1.05e-05	7.36e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—GSK3B—schizophrenia	1.04e-05	7.31e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—YWHAZ—schizophrenia	1.03e-05	7.26e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PLA2G4A—schizophrenia	1.02e-05	7.18e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NRG1—schizophrenia	1e-05	7.05e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	1e-05	7.03e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PRKD1—schizophrenia	9.99e-06	7.01e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MEF2C—schizophrenia	9.95e-06	6.99e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—ABCB1—schizophrenia	9.81e-06	6.89e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—YWHAZ—schizophrenia	9.62e-06	6.75e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ERBB3—schizophrenia	9.41e-06	6.6e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HTR2A—schizophrenia	9.05e-06	6.36e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—APOA1—schizophrenia	8.95e-06	6.28e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—schizophrenia	8.87e-06	6.23e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—AKT1—schizophrenia	8.71e-06	6.12e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—schizophrenia	8.69e-06	6.1e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—schizophrenia	8.69e-06	6.1e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—APOE—schizophrenia	8.42e-06	5.91e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GAPDH—schizophrenia	8.33e-06	5.85e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—APOA1—schizophrenia	8.32e-06	5.84e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL1B—schizophrenia	8.3e-06	5.83e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CLOCK—schizophrenia	8.26e-06	5.8e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—APOE—schizophrenia	8.24e-06	5.79e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	8.15e-06	5.72e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TPH2—schizophrenia	8.05e-06	5.65e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CACNB2—schizophrenia	8.05e-06	5.65e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ESR1—schizophrenia	8.03e-06	5.64e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—DPYD—schizophrenia	7.92e-06	5.56e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—APOA1—schizophrenia	7.75e-06	5.44e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—AKT1—schizophrenia	7.7e-06	5.4e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EP300—schizophrenia	7.58e-06	5.32e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—AKT1—schizophrenia	7.49e-06	5.26e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—EP300—schizophrenia	7.42e-06	5.21e-05	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—AKT1—schizophrenia	7.39e-06	5.19e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CACNA1C—schizophrenia	7.36e-06	5.17e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—AKT1—schizophrenia	7.34e-06	5.15e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—AKT1—schizophrenia	7.34e-06	5.15e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GSK3B—schizophrenia	7.29e-06	5.12e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PIK3C2A—schizophrenia	7.17e-06	5.04e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—AKT1—schizophrenia	7.08e-06	4.97e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—EP300—schizophrenia	6.85e-06	4.81e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—AKT1—schizophrenia	6.54e-06	4.59e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP2D6—schizophrenia	6.44e-06	4.52e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SNAP25—schizophrenia	6.44e-06	4.52e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—AKT1—schizophrenia	6.05e-06	4.25e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP1A2—schizophrenia	5.82e-06	4.09e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TH—schizophrenia	5.74e-06	4.03e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—schizophrenia	5.42e-06	3.81e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—EP300—schizophrenia	5.16e-06	3.62e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—COMT—schizophrenia	4.88e-06	3.42e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTP1—schizophrenia	4.85e-06	3.41e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MAOA—schizophrenia	4.84e-06	3.4e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EP300—schizophrenia	4.8e-06	3.37e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—EP300—schizophrenia	4.7e-06	3.3e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ABCB1—schizophrenia	4.59e-06	3.23e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—AKT1—schizophrenia	4.58e-06	3.22e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—AKT1—schizophrenia	4.48e-06	3.15e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTM1—schizophrenia	4.46e-06	3.13e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PLA2G4A—schizophrenia	4.46e-06	3.13e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—AKT1—schizophrenia	4.14e-06	2.91e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MTHFR—schizophrenia	3.94e-06	2.77e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—schizophrenia	3.69e-06	2.59e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOE—schizophrenia	3.67e-06	2.58e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOA1—schizophrenia	3.63e-06	2.55e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—schizophrenia	3.43e-06	2.41e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—AKT1—schizophrenia	3.12e-06	2.19e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AKT1—schizophrenia	2.9e-06	2.04e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—EP300—schizophrenia	2.09e-06	1.47e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—AKT1—schizophrenia	1.26e-06	8.87e-06	CbGpPWpGaD
